What Noxilizer does

Noxilizer is a privately held medical technology company that has commercialized a proprietary nitrogen dioxide (NO2) gas sterilization process operating at ultra-low temperatures of 10°C to 30°C. The company sells the UltraNox RTS Sterilizer product line in chamber sizes ranging from 400 liters to 16,000 liters, with single- and double-door configurations, optional minimal vacuum cycles for pressure-sensitive products, and integrated NO2 scrubbing. Cycle times of 6-12 hours including rapid aeration (minutes versus days for competing methods) and a mechanism of lethality based on DNA degradation with no cellular repair pathway distinguish the technology from conventional ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), and peracetic acid modalities. Noxilizer has secured first-mover regulatory milestones: an FDA-approved combination product (October 2024) and a first EMA authorization (April 2025), both for biotech drugs in prefilled syringes.

The company's business model combines capital equipment sales, contract sterilization services, and recurring support. Direct enterprise sales target pharmaceutical, biotech, and medical device manufacturers for in-house equipment installation, supplemented by on-site contract sterilization at the Hanover, MD headquarters and European facilities. Distribution is extended through CMO partnerships (equipment installed in Europe, US, and Asia) and a Sterigenics channel partnership for broader service access. Ancillary revenue includes feasibility studies (45-60 days), pre-validation, full sterilization validation (3-5 months) following ISO 14937, regulatory and design consulting, and consumables/technical support. Customers include Regeneron (intravitreal therapies), Terumo (polymer prefilled syringes), and multiple unnamed European and global biotech companies working on ophthalmic drug-device combinations and platform-wide therapeutic delivery systems.

Noxilizer operates from Hanover, Maryland with 11-50 employees and is venture-backed, most recently by a $30 million growth capital round led by NewVale Capital in September 2025. Leadership includes CEO Christopher A. Thatcher (appointed May 2024, prior Neuronetics CEO and 2018 IPO), Executive Chairman Lawrence Bruder, SVP R&D David Opie, Ph.D., and a board with representation from NewVale Capital partners. The company is positioned in a contract sterilization market projected to reach $9.11 billion by 2030 at a 9.4% CAGR, with growth catalyzed by EtO capacity constraints and regulatory remediation mandates driving demand for alternative sterilization modalities.

Name

Noxilizer

Legal name

Noxilizer, Inc.

Website

https://noxilizer.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Noxilizer provides room-temperature nitrogen dioxide (NO2) sterilization technology and UltraNox equipment for pharmaceutical, biotech, and medical device manufacturers, offering capital equipment sales, contract sterilization services, and validation support globally.

Ownership category

akta.pro rank

Product category

Sterilization Equipment

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Chemicals & Allied Products (2800), Miscellaneous Chemical Products (2890)

akta.pro primary industry

Sterilization Equipment & Systems (Autoclaves, Low-Temp, ETO, H2O2, UV) (HLAHANAA)

akta.pro secondary industries

Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB), Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers) (HLAHANAC)

Keywords

• Nitrogen dioxide sterilization
• Sterilization equipment manufacturing
• Contract sterilization services
• Pharmaceutical sterilization validation
• Medical device sterilization

Headquarters

HQ city

Hanover

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Sterilization Equipment Sales: Sale of UltraNox RTS Sterilizers ranging from 400L to 16,000L chamber sizes. Customers purchase equipment for installation in their own facilities or at CMOs.
2. Contract Sterilization Services: On-site contract sterilization at Hanover, MD facility and European locations. Provides terminal sterilization services for biopharmaceutical and medical device products.
3. Feasibility and Validation Studies: Sterilization testing services including feasibility studies (45-60 days), pre-validation studies, and full sterilization validation (3-5 months) following ISO 14937:2009.
4. Regulatory and Design Consulting: Consulting services for regulatory submissions, FDA pre-submission meeting requests, 510(k) process management, and drug-delivery system design for sterilization compatibility.
5. Consumables and Support Services: Customer and technical service, consumable product line, and ongoing support for installed equipment.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Noxilizer sells proprietary ultra-low temperature (10°C–30°C) nitrogen dioxide (NO2) gas sterilization technology to pharmaceutical, biotech, and medical device manufacturers. The company manufactures and sells UltraNox RTS Sterilizers (400L to 16,000L chambers) and offers contract sterilization services, feasibility/validation studies, regulatory consulting, and ongoing consumables/support.

Differentiator

Problem solved

Functional benefit

Products and services

• UltraNox RTS Sterilizers
• Contract Sterilization Services
• Feasibility and Validation Studies

Quantifiable outcome

• Cycle times of 6-12 hours including aeration vs. 1-4 weeks at external contract sterilizers
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• SterigenicscoreChannel Partner/ Reseller/ DistributorContract sterilization services partnership providing additional capacity for NO2 sterilization services. Allows customers to access NO2 sterilization through Sterigenics facilities.
• Contract Manufacturing Organizations (CMOs)coreChannel Partner/ Reseller/ DistributorCMOs install UltraNox NO2 Production Sterilizers to offer sterilization services. Equipment installed in Europe, US, and Asia. Expands geographic access and capacity for customers using CMO manufacturing model.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Sterigenics (Sotera Health): Largest global sterilization services provider offering EtO, gamma, and E-beam sterilization. Direct competitor to Noxilizer's contract sterilization services and a current partner/distribution channel for Noxilizer's NO2 technology across Sterigenics' global facilities.
• STERIS: Major medical sterilization equipment manufacturer and contract sterilization services provider. Competes broadly with Noxilizer across sterilization modalities and is a dominant player in hospital and pharmaceutical sterilization markets.
• Getinge: Global medical technology company with significant sterilization equipment business including low-temperature sterilization systems. Competes with Noxilizer's UltraNox sterilizer product line for medical device and pharmaceutical manufacturers.
• Bioquell (Ecolab): Provider of bio-decontamination systems using vaporized hydrogen peroxide (VHP) technology. Competes with Noxilizer's NO2 technology in pharmaceutical and medical device sterilization applications, particularly for sensitive products.
• Cantel Medical (now part of STERIS): Former independent provider of infection prevention and sterilization products for medical and dental markets. Acquired by STERIS, but historically competed with Noxilizer in medical sterilization and infection control segments.

Direct peers

• Fedegari Group: Italian manufacturer of sterilization equipment for pharmaceutical and medical device industries, including low-temperature systems. Direct competitor in pharmaceutical sterilization equipment market, especially in Europe.
• Tuttnauer: Manufacturer of sterilization and disinfection equipment for medical, laboratory, and pharmaceutical applications. Competes with Noxilizer in medical device and laboratory sterilization equipment markets.
• Cosmed Group: Contract sterilization services provider offering EtO and gamma sterilization for medical device and pharmaceutical industries. Direct competitor to Noxilizer's contract sterilization services business.
• E-BEAM Services: Provider of contract electron beam (E-beam) sterilization services for medical devices, pharmaceuticals, and consumer products. Competes with Noxilizer in the alternative sterilization methods market.
• Anderson Sterilizers (Steritec Products): Specializes in low-temperature sterilization equipment and contract sterilization services using proprietary methods. Most direct competitor to Noxilizer in alternative low-temperature sterilization for temperature-sensitive medical products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/noxilizer
• LinkedInlinkedin.com/company/noxilzer

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noxilizer